Psychiatrists give insight into managing treatment adherence in schizophrenia.
The unique attribute of agomelatine to reset circadian rhythms might be a cause for renewed interest within the pharmaceutical and medical communities.
Hearing loss is associated with higher levels of anxiety, interpersonal sensitivity, and hostility, as well as higher rates of dementia, especially in older adults who are also visually impaired.
Investigators posit that endogenous estrogen may have a protective effect against schizophrenia.
Asim Shah, MD, and Syed Z. Iqbal, MD, discuss the use of paliperidone to treat adult patients with schizophrenia.